Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP300909.RAQkFEPbEXFTEkYeY-ZmjWqiLtoVikMxpM782xUa_VQjw130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300909.RAQkFEPbEXFTEkYeY-ZmjWqiLtoVikMxpM782xUa_VQjw130_provenance.
• NP305778.RAc3urmMaHdl8tUimnLDKGT0Y_XMeTVi5uFIU6EJbARtE130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305778.RAc3urmMaHdl8tUimnLDKGT0Y_XMeTVi5uFIU6EJbARtE130_provenance.
• assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.
• NP1374009.RAUuU0hVsnoThE-3AYJr4CVAvXgYGY1Uq_9cVf55vuE6w130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374009.RAUuU0hVsnoThE-3AYJr4CVAvXgYGY1Uq_9cVf55vuE6w130_provenance.
• NP1374007.RAjNvEbXZNb0xhpKMIVOw4O7tyOfC4h2zJUESVRff8kds130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374007.RAjNvEbXZNb0xhpKMIVOw4O7tyOfC4h2zJUESVRff8kds130_provenance.
• NP308061.RAEt9QRMATTxgV8sBlZmYPsqbtKpeDwCfz8xEckDNOM0A130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308061.RAEt9QRMATTxgV8sBlZmYPsqbtKpeDwCfz8xEckDNOM0A130_provenance.
• NP678022.RA2MtCZ5CCQV4WvkSMtAosUBbf6bTYA7ZuJvxyt5ZHTaM130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678022.RA2MtCZ5CCQV4WvkSMtAosUBbf6bTYA7ZuJvxyt5ZHTaM130_provenance.
• NP680837.RA_Ydj-of1U0BgO7MnUoDk4Mr-7gxaDw9l_btioH8_3QQ130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680837.RA_Ydj-of1U0BgO7MnUoDk4Mr-7gxaDw9l_btioH8_3QQ130_provenance.
• NP1374008.RAK4d8ZwuKSsFNuhN-9PtyWoIFR3Ck4z-a79FNpz6BNUg130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374008.RAK4d8ZwuKSsFNuhN-9PtyWoIFR3Ck4z-a79FNpz6BNUg130_provenance.
• NP1374010.RAyDy3EgjAa1UXRdlymxv9E2jL1MiF8i0S2tew2GIFh5o130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374010.RAyDy3EgjAa1UXRdlymxv9E2jL1MiF8i0S2tew2GIFh5o130_provenance.